Valuation: Active Biotech AB

Market Cap 10Cr 1.01Cr 89.8L 83.66L 76.14L 1.43Cr 97Cr 1.44Cr 3.93Cr 49Cr 3.78Cr 3.7Cr 159.05Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 10Cr 1.01Cr 89.8L 83.66L 76.14L 1.43Cr 97Cr 1.44Cr 3.93Cr 49Cr 3.78Cr 3.7Cr 159.05Cr EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
83.01%
Yield 2026 *
-
Yield 2027 * -
1 week-5.66%
Current month-2.91%
1 month-21.89%
3 months-32.18%
6 months-44.82%
Current year-16.63%
1 week 3.65
Extreme 3.65
4.2
1 month 3.65
Extreme 3.65
5.05
3 years 3.65
Extreme 3.65
52.95
5 years 3.65
Extreme 3.65
52.95
10 years 3.65
Extreme 3.65
427.11
Manager TitleAgeSince
Chief Executive Officer 64 01/07/2017
Director of Finance/CFO 75 01/01/2000
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 70 07/04/2011
Chairman 61 23/05/2019
Director/Board Member 76 23/05/2019
Date Insider Type Main position Quantity % Market Cap. Importance
25/01/21 Buy

Director

24,261 -
25/01/21 Buy

Director

5,25,000 -
25/01/21 Buy

Director

9,35,000 -
Change 5-day change 1-year change 3-year change Capi.($)
-3.31%-5.13%-70.71%-83.59% 1.01Cr
+4.16%+3.42%+49.37%+94.17% 7.43TCr
+0.69%-3.58%+20.33%+74.94% 5.7TCr
+2.40%+0.92%+5.78%+37.39% 4.83TCr
+0.50%+2.94%+344.62%+722.17% 4.45TCr
+3.05%-1.80%+28.78%+34.51% 4.38TCr
+1.00%-1.46%+5.17%+111.90% 4.11TCr
-0.54%+2.41%+9.31%+58.85% 3.11TCr
+4.51%+8.22%+37.86%+32.49% 2.9TCr
+0.76%-1.45%-7.44%-11.12% 2.45TCr
Average +1.93%-0.15%+42.31%+107.17% 4.37TCr
Weighted average by Cap. +2.07%-0.46%+58.75%+136.76%

Financials

2026 *2027 *
Net sales - -
Net income -3.32Cr -33.06L -29.49L -27.48L -25L -47.09L -32Cr -47.44L -1.29Cr -16Cr -1.24Cr -1.21Cr -52Cr 1.82Cr 18.12L 16.17L 15.06L 13.71L 25.81L 17Cr 26L 70.81L 8.91Cr 68.03L 66.57L 29Cr
Net Debt - -
Logo Active Biotech AB
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Employees
-
Date Price Change Volume
06/26/06 SEK 3.700 -3.52% 49,629
05/26/05 SEK 3.835 +1.19% 28,439
02/26/02 SEK 3.790 -0.92% 31,488
01/26/01 SEK 3.825 -3.16% 36,213
30/26/30 SEK 3.950 +1.28% 2,29,111
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
B

Net sales - Rate of surprise